Tgf-β2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 300, Issue 4, 2011, Pages

  Singla, Dinender K ^a   Singla, Reetu D ^a   Lamm, Stephanie ^a   Glass, Carley ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

H9c2 cells; Iodoacetic acid; Myocardial infarction; Transforming growth factor 2

Indexed keywords

HYDROGEN PEROXIDE; INTERLEUKIN 10; IODOACETIC ACID; PROTEIN KINASE B; STEM CELL FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA2; VASCULOTROPIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL TRANSPLANTATION; CELL VIABILITY; CLINICAL EVALUATION; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYONIC STEM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROSIS; HEART FUNCTION; HEART INFARCTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CULTURE MEDIA, CONDITIONED; CYTOPROTECTION; EMBRYONIC STEM CELLS; FEMALE; HYDROGEN PEROXIDE; INDOLEACETIC ACIDS; INTERLEUKIN-10; MALE; MATRIX METALLOPROTEINASE 1; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; STEM CELL FACTOR; STEM CELL TRANSPLANTATION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA2; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 79955060751     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00917.2010     Document Type: Article

References (43)

1. Aki T, Yamaguchi K, Fujimiya T, Mizukami Y. Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocyte-derived cell line H9c2. Oncogene 22: 8529-8535, 2003.
2. Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, Kajstura J. Apoptosis and myocardial infarction. Basic Res Cardiol 93, Suppl 3: 8-12, 1998.
3. Anversa P, Olivetti G, Leri A, Liu Y, Kajstura J. Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens 6: 169-176, 1997.
4. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776, 2003.
5. Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344: 1750-1757, 2001.
6. Cicconi S, Ventura N, Pastore D, Bonini P, Di Nardo P, Lauro R, Marlier LN. Characterization of apoptosis signal transduction pathways in HL-5 cardiomyocytes exposed to ischemia/reperfusion oxidative stress model. J Cell Physiol 195: 27-37, 2003.
7. Dhingra S, Sharma AK, Singla DK, Singal PK. P38 and ERK1/2 MAPKs mediate the interplay of TNF-alpha and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol 293: H3524-H3531, 2007.
8. Dufour C, Holy X, Marie PJ. Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling. Am J Physiol Endocrinol Metab 294: E794-E801, 2008.
9. Elvers M, Pfeiffer J, Kaltschmidt C, Kaltschmidt B. TGF-beta2 neutralization inhibits proliferation and activates apoptosis of cerebellar granule cell precurors in the developing cerebellum. Mech Dev 122: 587-602, 2005.
10. Emgard M, Hallin U, Karlsson J, Bahr BA, Brundin P, Blomgren K. Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. J Neurochem 86: 1223-1232, 2003.
11. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156, 1981.
12. +ve progenitor cells and enhance neovascularization. Antioxid Redox Signal 13: 1857-1865, 2010.
13. Gatson JW, Singh M. Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 148: 2458-2464, 2007.
14. Gnecchi M, He H, Liang OD, Melo LG, Morello F, Mu H, Noiseux N, Zhang L, Pratt RE, Ingwall JS, Dzau VJ. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368, 2005.
15. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20: 661-669, 2006.
16. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628, 1994.
17. Haider HK, Ashraf M. Bone marrow cell transplantation in clinical perspective. J Mol Cell Cardiol 38: 225-235, 2005.
18. Haider HK, Ye L, Ashraf M. Skeletal muscle derived stem cells for myocardial repair. Recent Pat Cardiovasc Drug Discov 2: 205-213, 2007.
19. Hong F, Kwon SJ, Jhun BS, Kim SS, Ha J, Kim SJ, Sohn NW, Kang C, Kang I. Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Life Sci 68: 1095-1105, 2001.
20. Khan SA, Lopez-Chua CA, Zhang J, Fisher LW, Sorensen ES, Denhardt DT. Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors. J Cell Biochem 85: 728-736, 2002.
21. Kofidis T, de Bruin JL, Yamane T, Tanaka M, Lebl DR, Swijnenburg RJ, Weissman IL, Robbins RC. Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and hostspecific differentiation in the heart after ischemic myocardial injury. Circulation 111: 2486-2493, 2005.
22. Krijnen PA, Cillessen SA, Manoe R, Muller A, Visser CA, Meijer CJ, Musters RJ, Hack CE, Aarden LA, Niessen HW. Clusterin: a protective mediator for ischemic cardiomyocytes? Am J Physiol Heart Circ Physiol 289: H2193-H2202, 2005.
23. Kudo M, Wang Y, Wani MA, Xu M, Ayub A, Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 35: 1113-1119, 2003.
24. Kumar D, Hacker TA, Buck J, Whitesell LF, Kaji EH, Douglas PS, Kamp TJ. Distinct mouse coronary anatomy and myocardial infarction consequent to ligation. Coron Artery Dis 16: 41-44, 2005.
25. Kumar D, Jugdutt BI. Apoptosis and oxidants in the heart. J Lab Clin Med 142: 288-297, 2003.
26. Kumar D, Kamp TJ, LeWinter MM. Embryonic stem cells: differentiation into cardiomyocytes and potential for heart repair and regeneration. Coron Artery Dis 16: 111-116, 2005.
27. Kumar D, Kirshenbaum L, Li T, Danelisen I, Singal P. Apoptosis in isolated adult cardiomyocytes exposed to adriamycin. Ann NY Acad Sci 874: 156-168, 1999.
28. Kumar D, Lou H, Singal PK. Oxidative stress and apoptosis in heart dysfunction. Herz 27: 662-668, 2002.
29. Li G, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 inhibits apoptosis of human breast epithelial cells. Cancer Res 59: 6267-6275, 1999.
30. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 100: 1991-1999, 1997.
31. Liu XW, Bernardo MM, Fridman R, Kim HR. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J Biol Chem 278: 40364-40372, 2003.
32. Nishiyama K, Konishi A, Nishio C, Raki-Yoshida K, Hatanaka H, Kojima M, Ohmiya Y, Yamada M, Koshimizu H. Expression of cystatin C prevents oxidative stress-induced death in PC12 cells. Brain Res Bull 67: 94-99, 2005.
33. Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P. Cannabinoid- induced apoptosis in immune cells as a pathway to immunosuppression. Immunobiology 215: 598-605, 2010.
34. Shani V, Bromberg Y, Sperling O, Zoref-Shani E. Involvement of Src tyrosine kinases (SFKs) and of focal adhesion kinase (FAK) in the injurious mechanism in rat primary neuronal cultures exposed to chemical ischemia. J Mol Neurosci 37: 50-59, 2009.
35. Singla DK. Embryonic stem cells in cardiac repair and regeneration. Antioxid Redox Signal 11: 1857-1863, 2009.
36. Singla DK, Hacker TA, Ma L, Douglas PS, Sullivan R, Lyons GE, Kamp TJ. Transplantation of embryonic stem cells into the infracted mouse heart: formation of multiple cell types. J Mol Cell Cardiol 40: 195-200, 2006.
37. Singla DK, Lyons GE, Kamp TJ. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 293: H1308-H1314, 2007.
38. Singla DK, McDonald DE. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol Heart Circ Physiol 293: H1590-H1595, 2007.
39. Singla DK, Singla RD, McDonald DE. Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway. Am J Physiol Heart Circ Physiol 295: H907-H913, 2008.
40. Singla DK, Sun B. Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem Biophys Res Commun 332: 135-141, 2005.
41. van De Water B, Wang Y, Asmellash S, Liu H, Zhan Y, Miller E, Stevens JL. Distinct endoplasmic reticulum signaling pathways regulate apoptotic and necrotic cell death following iodoacetamide treatment. Chem Res Toxicol 12: 943-951, 1999.
42. Wang Y, Ahmad N, Wani MA, Ashraf M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J Mol Cell Cardiol 37: 1041-1052, 2004.
43. You KH, Ji YM, Kwon OY. Clusterin overexpression is responsible for the anti-apoptosis effect in a mouse neuroblastoma cell line, B103. Z Naturforsch C 58: 148-151, 2003.